March 05, 2015 1:30 AM ET


Company Overview of Teva Kutno S.A.

Company Overview

Teva Kutno S.A. produces and markets prescription medicines and over the counter (OTC) drugs. It offers medicines for type 2 diabetes, urological diseases, osteoporosis, central nervous system disorders, heart and respiratory diseases, transplantations, and cancer treatment. The company also provides an OTC product Vibovit, a multi-vitamin preparation. The company was formerly known as Polfa Kutno, S.A. The company was incorporated in 1948 and is based in Kutno, Poland. Teva Kutno S.A. operates as a subsidiary of Teva Pharmaceutical Industries Limited.

Ul.Sienkiewicza 25

Kutno,  99-300


Founded in 1948


48 24 355 0100


48 24 355 0350

Key Executives for Teva Kutno S.A.

President and Managing Director
Finance Director
Director and Ethical Medicines Segment Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Hependo Sp. z o. o. Europe
Apteki Cefarm Sp. z o.o. Europe
Polfa Warszawa S.A. Europe
Biosenso Sp. z o.o. Europe
US Pharmacia sp. z o.o. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Teva Kutno S.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at